CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-03 | El-Hibri Fuad Chairman | Sale | −20,000 | $90.74 | $1.8M | 1,123,988 |
| 2020-11-03 | El-Hibri Fuad Chairman | Option exercise · Stock Options (Right to Buy) | −20,000 | 39,391 | ||
| 2020-11-02 | El-Hibri Fuad Chairman | Option exercise | +20,000 | $26.45 | $529K | 1,143,988 |
| 2020-11-02 | El-Hibri Fuad Chairman | Sale | −20,000 | $90.44 | $1.8M | 1,123,988 |
| 2020-11-02 | El-Hibri Fuad Chairman | Option exercise · Stock Options (Right to Buy) | −20,000 | 59,391 | ||
| 2020-10-01 | White Marvin L Director | Grant or award | +3,629 | 3,629 | ||
| 2020-09-24 | El-Hibri Fuad Chairman | Sale | −12,535 | $98.85 | $1.2M | 1,123,988 |
| 2020-09-23 | El-Hibri Fuad Chairman | Sale | −13,000 | $100.58 | $1.3M | 1,136,523 |
| 2020-09-17 | El-Hibri Fuad Chairman | Sale | −20,000 | $100.68 | $2.0M | 1,149,523 |
| 2020-09-16 | SULLIVAN LOUIS W Director | Gift | −10,004 | 32,758 | ||
| 2020-09-16 | El-Hibri Fuad Chairman | Sale | −20,000 | $102.48 | $2.0M | 1,169,523 |
| 2020-09-10 | El-Hibri Fuad Chairman | Sale | −20,000 | $102.66 | $2.1M | 1,189,523 |
| 2020-09-09 | El-Hibri Fuad Chairman | Sale | −20,000 | $102.80 | $2.1M | 1,209,523 |
| 2020-09-02 | SULLIVAN LOUIS W Director | Sale | −20,525 | $111.22 | $2.3M | 42,762 |
| 2020-09-02 | SULLIVAN LOUIS W Director | Option exercise | +7,893 | $20.08 | $158K | 50,655 |
| 2020-09-02 | SULLIVAN LOUIS W Director | Sale | −7,893 | $111.23 | $878K | 42,762 |
| 2020-09-02 | SULLIVAN LOUIS W Director | Option exercise · Employee Stock Options (Right to Buy) | +7,893 | 15,786 | ||
| 2020-08-18 | Bailey Sue Director | Sale | −4,665 | $128.31 | $599K | 32,595 |
| 2020-08-17 | Harsanyi Zsolt Director | Sale | −6,609 | $133.71 | $884K | 24,579 |
| 2020-08-11 | JOULWAN GEORGE A Director | Sale | −6,000 | $124.11 | $745K | 26,771 |
Page 23 of 31 · 601 trades